KPRX
KPRX
NASDAQ · Pharmaceuticals

Kiora Pharmaceuticals Inc

$2.62
-0.09 (-3.32%)
As of Sep 23, 10:58 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,019.8% upside
Low Target $16.75
Average Target $29.34
High Target $32.13
Current Price $2.62
Current
$2.62
Target
$29.34
$16.75 $29.34 avg $32.13
Scenario Analysis
Bear Case
$16.75
539.3%
Low target
Base Case
$29.34
+1,019.8%
Avg target
Bull Case
$32.13
+1,126.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.95
-11.2% from high
52-Week Low
$1.76
+48.5% from low
Target vs 52W High
$29.34
+894.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +15.6%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +7.6%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +20.3%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +185.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -37.1%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +193.1%